Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Respir Med. 2016 Mar 21;114:53–60. doi: 10.1016/j.rmed.2016.03.012

Figure 2. Survival among patients with HP stratified by HPAF status.

Figure 2

Mean survival time in those with coexistent HP and autoimmune disease or features (HPAF) was 17.7 ± 12 months compared to 30.2 ± 22 months (p=0.59) in those with HP alone. HP = Hypersensitivity pneumonitis. AF = autoimmune features.